Erratum
for
Azad et al., J Clin Oncol 26 (22) 3709-3714.
Journal of Clinical Oncology, Vol 26, No 26 (September 10), 2008: pp. 4363
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.19.5180
ERRATUM
The August 1, 2008, article by Azad et al, entitled "Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity" (J Clin Oncol 26:3709-3714, 2008) contained an error. William D. Figg (Molecular Pharmacology Section and the Clinical Pharmacology Program, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD) was inadvertently omitted from the author list. The corrected author list is reprinted below in its entirety.
Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski, Seth M. Steinberg, Lokesh Jain, Christina M. Annunziata, Lori Minasian, Gisele Sarosy, Herbert L. Kotz, Ahalya Premkumar, Liang Cao, Deborah McNally, Catherine Chow, Helen X. Chen, John J. Wright, William D. Figg, and Elise C. Kohn. Dr. Figg has indicated that no potential conflicts of interest exist. In the Author Contributions section, Dr. Figg should have been acknowledged for: Conception and design, Financial support, Collection and assembly of data, Data analysis and interpretation. The online version has been corrected in departure from the print.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
